Otsuka Holdings Co Ltd is a pharmaceutical company. The Company manufactures, sells, imports and exports pharmaceuticals, clinical testing, and medical equipment for intractable diseases.

Otsuka Pharmaceutical Factory, Inc. And Icu Medical Announce The Establishment Of Joint Venture

Notice Regarding The Status Of Share Repurchases

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Otsuka Holdings (4578 JP)

Otsuka Pharmaceutical Factory, Inc. And Icu Medical Announce The Establishment Of Joint Venture

Notice Regarding The Status Of Share Repurchases

Changes Of Representative Director

Consolidated Financial Results For The Nine-Month Period Ended September 30, 2024 [Ifrs]

Otsuka Announces Positive Interim Results From The Phase 3 Trial Of Sibeprenlimab For The Treatment Of Immunoglobulin A Nephropathy In Adults

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)